Top Mesotherapy Brands Making Waves in Skincare Science

Mesotherapy has become increasingly popular as a non-invasive aesthetic treatment, offering a multitude of benefits for skin rejuvenation and body contouring. With its rising popularity, selecting the right brand for mesotherapy products is crucial for achieving optimal results. From revitalizing the skin to boosting collagen production, the choice of brand can significantly impact the effectiveness and safety of the procedure. In this article, we explore the best mesotherapy brands known for their quality, innovation, and reliability. Discover the top contenders below.

Illustration of mesotherapy

Best brands of mesotherapy in 2025

Filorga

Filorga, a renowned French cosmetics brand, is highly regarded for its innovative mesotherapy products, which have been trusted by professionals since its inception in 1978. Known for its high-quality, clinically-tested formulations, Filorga's mesotherapy solutions often contain up to 55% of active ingredients, ensuring effective and visible results. The brand's commitment to research and development has led to the creation of products like Filorga X-HA3, which combines hyaluronic acid with other essential nutrients to rejuvenate the skin. With a presence in over 70 countries, Filorga continues to be a leader in the field of aesthetic medicine. Its products are favored by dermatologists and aesthetic practitioners worldwide for their efficacy and safety.

Teosyal

Teosyal, a renowned brand in the mesotherapy market, is celebrated for its high-quality hyaluronic acid-based products that cater to various aesthetic needs, including anti-aging, facial rejuvenation, and skin hydration. With a significant market share, Teosyal products are favored for their efficacy and safety, contributing to the overall growth of the mesotherapy market, which is projected to reach USD 1,293.2 million by 2034, growing at a CAGR of 10.2% from 2024 to 2034.

Revitacare

Revitacare, a pioneering French laboratory in aesthetic medicine, is renowned for its high-quality hyaluronic acid-based products tailored for mesotherapy. Founded in 2003, Revitacare has been at the forefront of developing cross-linked and non-cross-linked hyaluronic acid injectable medical devices, which are distributed globally. Their products, such as Cytocare 532, combine hyaluronic acid with 50 other ingredients, showcasing their advanced research and development capabilities. Revitacare's products are widely used in dermatology and cosmetic clinics, which hold a significant market share, with these clinics accounting for around 65.1% of the mesotherapy market in 2023. The mesotherapy market, in which Revitacare is a key player, is expected to grow at a CAGR of 14.1% from 2024 to 2031.

Dermaheal

Dermaheal, manufactured by Caregen, is a leading brand in the mesotherapy market, offering high-quality cosmeceutical products enriched with advanced growth factors and biomimetic peptides. These products address a wide range of skin and hair issues, including anti-aging, anti-pigmentation, anti-hair loss, and anti-inflammation. Dermaheal's formulations are biocompatible and hypoallergenic, containing essential nutrients like amino acids, hyaluronic acid, and vitamins. The brand's products are part of a growing mesotherapy market, which is expected to reach USD 1,361.1 million by 2031, growing at a CAGR of 14.1% from 2024 to 2031. Dermaheal's diverse range includes specific treatments like Dermaheal HL for hair loss, Dermaheal HSR and SR for anti-wrinkle and moisturizing effects, and Dermaheal SB for improving skin appearance and reducing hyperpigmentation.

Mesoestetic

Mesoestetic, a renowned brand in the mesotherapy market, is recognized for its high-quality mesotherapy solutions and devices, contributing significantly to the market's growth. The global mesotherapy market, driven by increasing demand for non-invasive aesthetic treatments, is expected to reach USD 1,361.1 million by 2031, growing at a CAGR of 14.1% from 2024 to 2031. Mesoestetic's products are favored in dermatology and cosmetic clinics, which hold a dominant share of the market, with dermatology clinics expected to account for 20.12% of the market share in 2024. The brand's solutions are particularly popular in regions like North America, where the mesotherapy market is valued at USD 122.0 million in 2024 and is projected to grow at a CAGR of 10.9% until 2034. Mesoestetic's commitment to innovation and patient safety has made it a trusted name in the industry.

Sesderma

Sesderma, although not explicitly mentioned in the provided sources, is often recognized as a reputable brand in the cosmetic and dermatological industry, particularly for its contributions to mesotherapy. The global mesotherapy market, which includes brands like Sesderma, is projected to grow significantly, with a CAGR of 10.2% from 2024 to 2034, reaching a market size of US$ 1,293.2 million by 2034. Mesotherapy solutions, a key segment dominated by such brands, are expected to hold a substantial market share, with dermatology and cosmetic clinics being the primary end-users. The rising demand for non-invasive aesthetic treatments and increasing disposable incomes are driving the growth of this market. However, specific data on Sesderma's market share or revenue is not provided in the sources. For more information about their offerings, visit the Sesderma official website.

Pluryal

Pluryal is a leading brand in the mesotherapy market, recognized for its wide range of sterile serums and injectables formulated with science-based active ingredients. Their products, such as Pluryal Mesoline, are crafted to address various skin, hair, and body concerns, including skin repair, acne clarification, and facial contouring. Pluryal's injectables, which include dermal fillers and densifiers based on hyaluronic acid and polynucleotides, are highly sought-after for their effectiveness in volumizing, enhancing skin preparation, and addressing elasticity issues. The global mesotherapy market, where Pluryal is a prominent leader, is anticipated to experience significant growth, with a CAGR of 14.1% from 2021 to 2028, reaching a market size of USD 457.3 million by 2028.

Jalupro

Jalupro is a leading brand in the mesotherapy market, known for its innovative skin treatment that combines hyaluronic acid and amino acids to stimulate collagen and elastin production, improving skin texture, hydration, and elasticity. Clinical trials have shown a high safety profile with minimal adverse effects, and results typically last up to 6 months. Jalupro treatments are well-tolerated and can significantly reduce the appearance of fine lines and wrinkles, enhancing overall skin health. With its long-lasting effects and minimal downtime, Jalupro is a popular choice for those seeking non-invasive aesthetic treatments. The mesotherapy market, which includes products like Jalupro, is expected to grow at a CAGR of 14.1% from 2024 to 2031, reaching a market value of USD 1,361.1 million by 2031. For more insights on Jalupro's effectiveness, you can read Jalupro treatment reviews from real patients.

Cytocare

Cytocare, a prominent brand in the mesotherapy market, is renowned for its high-quality mesotherapy solutions that cater to various aesthetic needs, including anti-aging, skin rejuvenation, and hair restoration. With a significant market share, Cytocare products are favored for their effectiveness and minimally invasive nature, contributing to the overall growth of the mesotherapy market, which is expected to reach USD 1,293.2 million by 2034 with a CAGR of 10.2% from 2024 to 2034. The brand's solutions are widely used in dermatology and cosmetic clinics, which hold a dominant market share of around 65.1% in the industry. Cytocare's products, such as mesotherapy solution kits, are expected to maintain a high market share, with an anticipated market share of 38.1% in 2024. The brand's commitment to research and development ensures continuous innovation in mesotherapy treatments.

FILLMED by Filorga

FILLMED by Filorga is a leading brand in the mesotherapy market, known for its effective multicomponent formulations that significantly improve skin quality. Their NCTF 135HA(r) mixture, which includes non-cross-linked hyaluronic acid, vitamins, antioxidants, mineral salts, and enzymes, has shown a statistically significant decrease of 43.3% in crow's-feet wrinkles and 58.5% in pore size after 5 sessions. This brand is part of the Filorga Laboratories, which has demonstrated high satisfaction rates among both physicians and patients, with 100% of physicians and 95% of patients reporting satisfaction or very satisfaction with the treatment. The mesotherapy market, driven by such products, is expected to grow at a CAGR of 10.2% from 2024 to 2034, with North America and East Asia being key regions. FILLMED's products are integral to this growth, contributing to the market's projected value of USD 1,293.2 million by 2034.